Association between quality metric adherence and overall survival among patients undergoing resection of pancreatic ductal adenocarcinoma

被引:0
|
作者
Munir, Muhammad Musaab [1 ]
Rashid, Zayed [1 ]
Endo, Yutaka [1 ]
Dillhoff, Mary [1 ]
Tsai, Susan [1 ]
Pawlik, Timothy M. [1 ]
机构
[1] Ohio State Univ, Wexner Med Ctr, Dept Surg, 395 W 12th Ave,Suite 670, Columbus, OH 43210 USA
关键词
LENGTH-OF-STAY; CANCER CARE; PANCREATICODUODENECTOMY;
D O I
10.1016/j.surg.2024.04.043
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Process-based quality metrics are important for improving long-term outcomes after surgical resection. We sought to develop a practical surgical quality score for patients diagnosed with pancreatic ductal adenocarcinoma undergoing curative-intent resection. Methods: Patients who underwent surgical resection for pancreatic ductal adenocarcinoma between 2010 and 2017 were identified using the National Cancer Database. Five surgical quality metrics were defined: minimally invasive approach, adequate lymphadenectomy, negative surgical margins, receipt of adjuvant therapy, and no prolonged hospitalization. Log-rank test and multivariable Cox regression analysis were used to determine the association of quality metrics with overall survival. Results: A total of 38,228 patients underwent curative-intent resection for pancreatic ductal adenocarcinoma. Median age at diagnosis was 68 years (interquartile range = 61-75), and roughly half the cohort was male (n = 19,562; 51.2%). Quality metrics were achieved on a varied basis: minimally invasive approach (n = 5,701; 14.9%), adequate lymphadenectomy (n = 27,122; 80.0%), negative surgical margin (n = 29,248; 76.5%), receipt of adjuvant therapy (n = 26,006; 68.0%), and absence of prolonged hospitalization (n = 26,470; 69.2%). An integer-based surgical quality score from 0 (no quality metrics) to 16 (all quality metrics) was calculated. Patients with higher scores had progressively better overall survival. Median overall survival differed substantially among the score categories (score = 0-4 points, 8.7 [8.0-9.6] months; 5-8 points, 17.5 [16.9-18.2] months; 9-12 points, 22.1 [21.6-22.8] months; and 13-16 points, 30.8 [30.2-31.3] months; P < .001). On multivariable analysis, risk-adjusted mortality hazards decreased in a stepwise manner with higher scores (0-4 points: reference; 5-8 points: multivariable adjusted hazard ratio = 0.60; 95% CI, 0.57-0.63; 9-12 points: adjusted hazard ratio = 0.49; 95% CI, 0.47-0.52; 13-16 points: and adjusted hazard ratio = 0.37; 95% CI, 0.34-0.40; all P < .001). Conclusion: Adherence to quality metrics may be associated with improved overall survival. Efforts aimed at increasing compliance with quality metric measures may help optimize long-term outcomes among patients undergoing surgical resection for pancreatic ductal adenocarcinoma. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 50 条
  • [21] Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving Chemotherapy
    Fulop, Daniel J.
    Zylberberg, Haley M.
    Wu, Y. Linda
    Aronson, Anne
    Labiner, Arielle J.
    Wisnivesky, Juan
    Cohen, Deirdre J.
    Sigel, Keith M.
    Lucas, Aimee L.
    JAMA NETWORK OPEN, 2023, 6 (03) : E234254
  • [22] Association of lung immune prognostic index with overall survival in pancreatic ductal adenocarcinoma patients treated using chemotherapy
    Zhang, Nan
    Deng, Guochao
    Jia, Ru
    Han, Quanli
    Dai, Guanghai
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2025, 22 (07): : 1672 - 1679
  • [23] Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical resection
    Xu, Yaolin
    Zhang, Yueming
    Wu, Zizhen
    Wang, Dansong
    Wu, Wenchuan
    Kuang, Tiantao
    Lou, Wenhui
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (06) : 679 - 687
  • [24] Peripheral Eosinophil Count May Be the Prognostic Factor for Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Treatment
    Ciesielski, Wojciech
    Kuprys-Lipinska, Izabela
    Kumor-Kisielewska, Anna
    Grzasiak, Oliwia
    Borodacz, Julia
    Niedzwiecki, Sebastian
    Hogendorf, Piotr
    Durczynski, Adam
    Strzelczyk, Janusz
    Majos, Alicja
    BIOMEDICINES, 2024, 12 (11)
  • [25] Steady Progress and Improving Survival for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma
    Underwood, Patrick W.
    Riner, Andrea N.
    Herremans, Kelly M.
    Trevino, Jose G.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 454 - 454
  • [26] Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer
    Cerullo, Marcelo
    Gani, Faiz
    Chen, Sophia Y.
    Canner, Joseph K.
    Pawlik, Timothy M.
    WORLD JOURNAL OF SURGERY, 2017, 41 (09) : 2361 - 2370
  • [27] Impact of Angiotensin Receptor Blocker Use on Overall Survival Among Patients Undergoing Resection for Pancreatic Cancer
    Marcelo Cerullo
    Faiz Gani
    Sophia Y. Chen
    Joseph K. Canner
    Timothy M. Pawlik
    World Journal of Surgery, 2017, 41 : 2361 - 2370
  • [28] Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal Adenocarcinoma
    Motokazu Sugimoto
    Michael B. Farnell
    David M. Nagorney
    Michael L. Kendrick
    Mark J. Truty
    Rory L. Smoot
    Suresh T. Chari
    Michael R. Moynagh
    Gloria M. Petersen
    Rickey E Carter
    Naoki Takahashi
    Journal of Gastrointestinal Surgery, 2018, 22 : 831 - 839
  • [29] Improved overall survival for patients with early-onset pancreatic ductal adenocarcinoma.
    Nair, Kanika G.
    Kamath, Suneel Deepak
    Wei, Wei
    Tullio, Katherine
    Estfan, Bassam N.
    Khorana, Alok A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [30] Preoperative plasma D-dimer independently predicts survival in patients with pancreatic ductal adenocarcinoma undergoing radical resection
    Chen, Haoda
    Li, Fanlu
    Zou, Siyi
    Xie, Junjie
    Zhang, Jun
    Deng, Xiaxing
    Chen, Hao
    Shen, Baiyong
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)